Clinical Trial Update: Effects of dapaglifloziN Therapy on Myocardial Perfusion Reserve in Prediabetic Patients With Stable coronarY Artery Disease [Phase 4]

View source ↗

Summary

Phase 4 trial update on dapagliflozin therapy effects for myocardial perfusion reserve in prediabetic patients with stable coronary artery disease; study termin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Prediabetic State

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: CHEOL WHAN LEE, M.D., Ph.D | Conditions: Coronary Artery Disease, Prediabetic State | Phase 4 | Status: TERMINATED